Inflammation and insulin resistance
- PMID: 16823477
- PMCID: PMC1483173
- DOI: 10.1172/JCI29069
Inflammation and insulin resistance
Erratum in
- J Clin Invest. 2006 Aug;116(8):2308
Abstract
Over a hundred years ago, high doses of salicylates were shown to lower glucose levels in diabetic patients. This should have been an important clue to link inflammation to the pathogenesis of type 2 diabetes (T2D), but the antihyperglycemic and antiinflammatory effects of salicylates were not connected to the pathogenesis of insulin resistance until recently. Together with the discovery of an important role for tissue macrophages, these new findings are helping to reshape thinking about how obesity increases the risk for developing T2D and the metabolic syndrome. The evolving concept of insulin resistance and T2D as having immunological components and an improving picture of how inflammation modulates metabolism provide new opportunities for using antiinflammatory strategies to correct the metabolic consequences of excess adiposity.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483173/bin/JCI0629069.f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483173/bin/JCI0629069.f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483173/bin/JCI0629069.f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483173/bin/JCI0629069.f4.gif)
Similar articles
-
Role of immune cells in obesity induced low grade inflammation and insulin resistance.Cell Immunol. 2017 May;315:18-26. doi: 10.1016/j.cellimm.2017.03.001. Epub 2017 Mar 7. Cell Immunol. 2017. PMID: 28285710 Review.
-
Macrophages, immunity, and metabolic disease.Immunity. 2014 Jul 17;41(1):36-48. doi: 10.1016/j.immuni.2014.05.010. Immunity. 2014. PMID: 25035952 Review.
-
Why do anti-inflammatory therapies fail to improve insulin sensitivity?Acta Pharmacol Sin. 2012 Feb;33(2):182-8. doi: 10.1038/aps.2011.131. Epub 2011 Oct 31. Acta Pharmacol Sin. 2012. PMID: 22036866 Free PMC article. Review.
-
Therapeutic approaches to target inflammation in type 2 diabetes.Clin Chem. 2011 Feb;57(2):162-7. doi: 10.1373/clinchem.2010.148833. Epub 2010 Nov 22. Clin Chem. 2011. PMID: 21098138 Free PMC article. Review.
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
Cited by
-
Potential molecular mechanism of exercise reversing insulin resistance and improving neurodegenerative diseases.Front Physiol. 2024 May 16;15:1337442. doi: 10.3389/fphys.2024.1337442. eCollection 2024. Front Physiol. 2024. PMID: 38818523 Free PMC article. Review.
-
Interacting and joint effects of triglyceride-glucose index and hypertension on stroke risk in middle-aged and older Chinese adults: a population-based prospective cohort study.Front Cardiovasc Med. 2024 May 15;11:1363049. doi: 10.3389/fcvm.2024.1363049. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38812746 Free PMC article.
-
Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities.MedComm (2020). 2024 May 24;5(6):e560. doi: 10.1002/mco2.560. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38812572 Free PMC article. Review.
-
The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet.Gut Microbes. 2024 Jan-Dec;16(1):2356270. doi: 10.1080/19490976.2024.2356270. Epub 2024 May 26. Gut Microbes. 2024. PMID: 38797998 Free PMC article.
-
Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes.Cardiovasc Diabetol. 2024 May 16;23(1):171. doi: 10.1186/s12933-024-02269-0. Cardiovasc Diabetol. 2024. PMID: 38755682 Free PMC article.
References
-
- Ebstein W. Zur therapie des Diabetes mellitus, insbesondere über die Anwendung des salicylsauren Natron bei demselben. Berliner Klinische Wochenschrift. 1876;13:337–340.
-
- Shoelson S. Invited comment on W. Ebstein: on the therapy of diabetes mellitus, in particular on the application of sodium salicylate. J. Mol. Med. 2002;80:618–619. - PubMed
-
- Hecht A., Goldner M.G. Reappraisal of the hypoglycemic action of acetylsalicylate. Metabolism. 1959;8:418–428. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical